Countries citing papers authored by Megan E. Cavet
Since
Specialization
Citations
This map shows the geographic impact of Megan E. Cavet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Megan E. Cavet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Megan E. Cavet more than expected).
This network shows the impact of papers produced by Megan E. Cavet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Megan E. Cavet. The network helps show where Megan E. Cavet may publish in the future.
Co-authorship network of co-authors of Megan E. Cavet
This figure shows the co-authorship network connecting the top 25 collaborators of Megan E. Cavet.
A scholar is included among the top collaborators of Megan E. Cavet based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Megan E. Cavet. Megan E. Cavet is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Cavet, Megan E., et al.. (2021). In Vitro Potency of Tobramycin Against Common Bacterial Pathogens Implicated in Blepharitis. Investigative Ophthalmology & Visual Science. 62(8). 414–414.1 indexed citations
5.
Cavet, Megan E. & Heleen H. DeCory. (2021). Occurrence of steroid-associated adverse events with loteprednol etabonate formulations. Investigative Ophthalmology & Visual Science. 62(8). 720–720.1 indexed citations
Sanfilippo, Christine M., Megan E. Cavet, Heleen H. DeCory, & Penny A. Asbell. (2018). Antibiotic Resistance in Ocular Pathogens – Preliminary Results from the 2017 ARMOR Surveillance Program. Investigative Ophthalmology & Visual Science. 59(9). 2659–2659.1 indexed citations
9.
Asbell, Penny A., Christine M. Sanfilippo, Megan E. Cavet, & Heleen H. DeCory. (2018). Antibiotic Resistance Trends Among Staphylococci in the ARMOR Study: 2009-2017. Investigative Ophthalmology & Visual Science. 59(9). 3676–3676.1 indexed citations
10.
Cavet, Megan E., Christine M. Sanfilippo, & Heleen H. DeCory. (2017). Assessment of ophthalmic steroid class adverse event reports for loteprednol etabonate. Investigative Ophthalmology & Visual Science. 58(8). 1082–1082.3 indexed citations
Cavet, Megan E., Heleen H. DeCory, & John D. Sheppard. (2016). Impact of the topical ophthalmic corticosteroid loteprednol etabonate on intraocular pressure. Investigative Ophthalmology & Visual Science. 57(12). 5405–5405.1 indexed citations
13.
Cavet, Megan E., et al.. (2015). Ocular pharmacokinetics of submicron loteprednol etabonate ophthalmic gel, 0.38% following topical administration in rabbits. Investigative Ophthalmology & Visual Science. 56(7). 1524–1524.1 indexed citations
14.
Cavet, Megan E., Thomas Vollmer, Karen Harrington, Karl R. VanDerMeid, & Mary Richardson. (2014). NO-induced Regulation of Primary Human Trabecular Meshwork Cell Contractility by Latanoprostene Bunod. Investigative Ophthalmology & Visual Science. 55(13). 546–546.1 indexed citations
15.
Vollmer, Thomas, et al.. (2014). Anti-inflammatory effects of the glucocorticoid loteprednol etabonate in human ocular and inflammatory cells. Investigative Ophthalmology & Visual Science. 55(13). 6297–6297.1 indexed citations
16.
Cavet, Megan E., et al.. (2013). Anti-allergic effects of mapracorat, a novel selective glucocorticoid receptor agonist, in human conjunctival fibroblasts and epithelial cells.. Europe PMC (PubMed Central).17 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.